A Standardized Plaque Reduction Assay for Determination of Drug Susceptibilities of Cytomegalovirus Clinical Isolates

Twelve laboratories collaborated in formulating and testing a standardized plaque reduction assay for cytomegalovirus (CMV) cell-associated clinical isolates. Four characterized and plaque-purified CMV strains, as well as six coded clinical isolates obtained after antiviral therapy, were distributed...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Landry, Marie L., Stanat, Sylvia, Biron, Karen, Brambilla, Donald, Britt, William, Jokela, Janet, Chou, Sunwen, Drew, W. Lawrence, Erice, Alejo, Gilliam, Bruce, Lurain, Nell, Manischewitz, Jody, Miner, Richard, Nokta, Mostafa, Reichelderfer, Patricia, Spector, Stephen, Weinberg, Adriana, Yen-Lieberman, Belinda, Crumpacker, Clyde
التنسيق: Artigo
اللغة:Inglês
منشور في: American Society for Microbiology 2000
الموضوعات:
Antiviral Agents
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC89747/
https://ncbi.nlm.nih.gov/pubmed/10681339
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة